- Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections. Joshi, M., Anthony, W.C., Tenney, J.H., Drusano, G.L., Caplan, E.S., Standiford, H.C., Henson, A., Warren, J.W. Antimicrob. Agents Chemother. (1986)